Sound Pharmaceuticals Stock

soundpharmaceuticals.comHealthcareFounded: 2018Funding to Date: $25.95MM

Sound Pharmaceuticals is a bio-pharmaceutical platform developing novel treatments to prevent and treat hearing loss and tinnitus. The company uses molecular biology, immunohistochemistry and electrophysiology that have lead to the development of preclinical models of hearing loss and tinnitus that are translating into successful clinical trials.

Register for Details

For more details on financing and valuation for Sound Pharmaceuticals, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for Sound Pharmaceuticals.

Register Today

Sound Pharmaceuticals investors also invested in these private companies

KEC Ventures
Cystic Fibrosis Foundation

Team

Management Team

John Sullivan
Chief Financial Officer
Jonathan Kil
Chief Executive Officer & Chief Medical Officer

Other companies like Sound Pharmaceuticals in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.67B
Sector
 
 
Sector
Last Round Est. Valuation
$317.32MM
Sector
Last Round Est. Valuation
$334.19MM
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$1.59B
Sector
Last Round Est. Valuation
$4.26B
Sector